Insider trades
Chad M. Robins, Chairman of Adaptive Biotechnologies ADPT, has filed 0 purchases and 25 sales on the open market. Over the past 12 months that comes to a net sale of $24.9M. The latest trade was on 04/08.
Chad M. Robins
CEO and Chairman
- First filing
- 23/03/08
- Trades
- 41 trades
- Buys / sales
- 0 / 25
- 12-month net buying
- −$24.9M
- Last trade
- 04/08
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADPT | Open-market sale10b5-1 plan | 04/06–04/08 | 04/08 | 120,595 sh2 trades | $14.65avg. | $1,766,839.09 | −5.2% |
ADPT | Open-market sale | 03/11 | 03/13 | 470,167 sh2 trades | $13.17avg. | $6,192,099.39 | −17.0% |
ADPT | Open-market sale10b5-1 plan | 02/27–03/03 | 03/03 | 524,998 sh4 trades | $15.85avg. | $8,320,613.24 | −21.3% |
| Open-market sale10b5-1 plan | 02/02 | 02/04 | 124,998 sh | $18.44 | $2,304,963.12 | −4.8% | |
| Open-market sale10b5-1 plan | 01/05 | 01/07 | 124,998 sh | $15.59 | $1,948,718.82 | −4.6% | |
ADPT | Open-market sale10b5-1 plan | 25/11/26–25/12/01 | 25/12/01 | 160,734 sh2 trades | $19.10avg. | $3,070,746.6 | −5.6% |
ADPT | Open-market sale10b5-1 plan | 25/11/10–25/11/12 | 25/11/12 | 89,265 sh3 trades | $14.73avg. | $1,315,179.62 | −3.0% |
ADPT | Open-market sale | 25/03/05–25/03/06 | 25/03/06 | 219,569 sh3 trades | $7.29avg. | $1,600,416.95 | −6.9% |
ADPT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 285,187 sh2 trades | $8.45avg. | $2,410,699.88 | −10.0% |
ADPT | Open-market sale10b5-1 plan | 25/02/13–25/02/18 | 25/02/18 | 470,368 sh3 trades | $8.47avg. | $3,985,753.94 | −15.4% |
ADPT | Open-market sale | 24/03/05 | 24/03/06 | 48,673 sh2 trades | $3.43avg. | $167,007.18 | −1.9% |